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Abstract. The GTP-bound form of elongation factor Tu (EF-Tu) brings aminoacylated tRNAs (aa-tRNA) 
to the A-site of the ribosome. EF-Tu binds all cognate elongator aa-tRNAs with highly similar affinities, 
and its weaker or tighter binding of misacylated tRNAs may discourage their participation in translation. 
Norvaline (Nva) is a non-proteinogenic amino acid that is activated and transferred to tRNALeu by leucyl-
tRNA synthetase (LeuRS). No notable accumulation of Nva-tRNALeu has been observed in vitro, because 
of the efficient post-transfer hydrolytic editing activity of LeuRS. However, incorporation of norvaline in-
to proteins in place of leucine does occur under certain conditions in vivo. Here we show that EF-Tu binds 
Nva-tRNALeu and Leu-tRNALeu with similar affinities, and that Nva-tRNALeu and Leu-tRNALeu dissociate 
from EF-Tu at comparable rates. The inability of EF-Tu to discriminate against norvaline may have driven 
evolution of highly efficient LeuRS editing as the main quality control mechanism against 
misincorporation of norvaline into proteins. (doi: 10.5562/cca2173)  
Keywords: EF-Tu, norvaline, non-proteinogenic amino acids, aminoacyl-tRNA synthetases, leucyl-tRNA 
synthetase, mistranslation  
 
INTRODUCTION 
Bacterial elongation factor Tu (EF-Tu) delivers 
elongator aminoacyl-tRNAs (aa-tRNA) to the ribosome, 
where they are utilized in protein synthesis.1,2 EF-Tu 
belongs to a group of G-binding proteins that alternate 
between inactive and active forms by a mechanism 
involving the exchange of GDP with GTP. The GTP-
bound form (EF-Tu:GTP) binds all elongator aa-tRNAs 
with very similar affinities in the nanomolar range,3–5 
thus enabling a consistent rate of protein translation. In 
contrast, the GDP-bound form (EF-Tu:GDP) possesses 
rigorously decreased affinity for aa-tRNAs.6–8 Coupling 
of aa-tRNA binding by EF-Tu with its GTP/GDP cycle 
is important for accurate recognition of aa-tRNAs on the 
ribosome. Binding of the ternary EF-Tu:GTP:aa-tRNA 
complex to a cognate mRNA codon triggers the GTP-
ase activity, which releases cognate aminoacylated 
tRNA for binding in the ribosomal A site.2 
Interestingly, EF-Tu:GTP displays substantial 
specificity for both the amino acid and the tRNA por-
tions of its aa-tRNA ligands.4,5,9 The nearly uniform 
binding affinity observed for tRNAs aminoacylated with 
their cognate amino acid arises from thermodynamic 
compensation in binding the tRNA body and the esteri-
fied amino acid.3–5 Thus, weak-binding amino acids are 
esterified to cognate tRNAs that bind EF-Tu tightly, 
while tight-binding amino acids are matched with 
tRNAs that bind EF-Tu weakly. Strong thermodynamic 
contribution of either the esterified amino acid or the 
tRNA body, therefore, compensates for the weak ther-
modynamic contribution of another portion of the cog-
nate aa-tRNA pair. In contrast, tRNAs acylated with 
non-cognate amino acids (misacylated tRNAs) bind EF-
Tu with a broad range of affinities, varying from 60-fold 
weaker to 120-fold tighter than cognate aa-tRNAs. This 
allows EF-Tu to discriminate against at least some 
misacylated tRNAs, discouraging their further participa-
tion in translation.10–12 
Aminoacyl-tRNA synthetases (aaRSs) covalently 
link amino acids with cognate tRNAs in a two-step 
synthetic reaction that proceeds via an aminoacyl-
adenylate intermediate.13 Norvaline (Nva) is a non-
proteinogenic amino acid that may increase in concen-
tration to as high as 1 mmol dm–3 during unlimited 
growth of Escherichia coli on glucose after a down-shift 
in oxygen levels.14 Interestingly, a low but readily de-
tectable incorporation of norvaline for leucine was ob-
served in recombinant human hemoglobin produced in 
E. coli, and the extent of misincorporation strongly 
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correlated with the ratio of free norvaline to leucine.15 
Thus, under conditions that promote norvaline accumu-
lation, leucyl-tRNA synthetase (LeuRS) catalyzes for-
mation of Nva-tRNALeu in vivo. Norvaline possesses a 
linear three-carbon side chain that cannot be excluded 
from the LeuRS amino acid binding site on steric 
grounds (Figure 1a), preventing efficient discrimination 
in the synthetic reactions alone. Therefore, to achieve 
the accuracy required for protein synthesis, LeuRS pos-
sesses intrinsic hydrolytic editing activities to exclude 
norvaline. It is now well established that many aaRSs 
are incapable of efficient discrimination between cog-
nate and structurally similar non-cognate amino acids in 
the synthetic reactions.16,17 These enzymes therefore 
evolved editing mechanisms to hydrolyze non-cognate 
intermediates (pre-transfer editing) and/or misacylated 
tRNAs (post-transfer editing).16 
Work in our and other laboratories has shown that 
E. coli LeuRS indeed treats norvaline as a reasonably 
good substrate in the synthetic reactions; kcat/Km in acti-
vation is decreased only 100-fold as compared with 
leucine,18,19 while the rate of aminoacyl transfer to 
tRNA is identical.19 Despite this, we did not observe 
significant steady-state accumulation of Nva-tRNALeu in 
vitro due to the rapid clearance of Nva-tRNALeu by the 
post-transfer editing activity19 located on the separate 
editing domain known as the CP1 (connective peptide 
1) domain.20,21 We also demonstrated that dissociation 
of Nva-tRNALeu followed by rebinding and subsequent 
hydrolysis is a competent kinetic pathway.19 To test if 
any Nva-tRNALeu that evades hydrolytic correction is a 
substrate for ribosomal protein synthesis, its interaction 
with E. coli EF-Tu:GTP was studied at low (4 °C) and 
physiological (37 °C) temperatures. Using slightly mod-
ified versions of the ribonuclease (RNase) protec-
tion3,4,22 and non-enzymatic hydrolysis protection as-
says,23,24 we show that E. coli EF-Tu does not differen-
tiate between Leu-tRNALeu and Nva-tRNALeu at either 
temperature. The lack of discrimination against 
norvaline by EF-Tu highlights the importance of rapid 
hydrolytic correction by LeuRS, demonstrating that it 
provides the main line of defense against 
misincorporation of norvaline into proteins. Enhanced 
understanding of the molecular events that maintain 
selectivity against non-proteinogenic and/or non-natural 
amino acids may advance the engineering of proteins 
with desired features.25,26 
 
EXPERIMENTAL 
Cloning, Overexpression and Purification of  
N-His6-EF-Tu 
The E. coli tufB gene was PCR-amplified as a BamHI-
XhoI cassette and cloned into expression vector 
pPROEXHtb. This construct enables overexpression of 
EF-Tu with an N-terminal (His6)-TEV (tobacco etch 
virus) cleavable sequence. E. coli BL21(DE3) cells 
transformed with the pPROEXHtb-EcEFTu plasmid 
were grown to OD600 of 0.6–0.8 at 37 °C, induced with 
0.2 mol dm–3 IPTG and allowed to grow for 3 h. Over-
expressed N-His6-EF-Tu was purified by a standard 
procedure employing affinity chromatography on Ni2+-
nitrilotriacetic acid (Ni2+-NTA) resin. Briefly, the cells 
were lysed by sonication in buffer containing 50 mmol 
dm–3 Hepes-KOH (pH = 7.5), 10 mmol dm–3 MgCl2, 0.5 
mol dm–3 NaCl, glycerol (φ = 5 %), 100 μmol dm–3 
GDP, 5 mmol dm–3 β-mercaptoethanol and 10 mmol 
dm–3 imidazole. The lysate was cleared by centrifuga-
tion, followed by filtration through a 0.22 µm cellulose 
acetate filter. The filtrate was loaded onto a 1 mL Ni2+-
NTA resin and washed with 30 column volumes of lysis 
Figure 1. E. coli EF-Tu prepared by the standard Ni2+-NTA purification procedure contains traces of copurified endogenous
E. coli LeuRS. Molecular structures of leucine and norvaline (a). Representative leucylation time course with 12.5 µmol dm–3
EF-Tu:GDP before (●) and after (♦) additional purification by size-exclusion chromatography. The amount of LeuRS that con-
taminates EF-Tu was estimated by comparing leucylation rates of 12.5 µmol dm–3 EF-Tu (total protein concentration) and
2 nmol dm–3 LeuRS (○) (b). Representative Nva-[32P]-tRNALeu deacylation time courses in the absence of EF-Tu (○) and in the
presence of activated (●) or purified and activated EF-Tu (♦) (c).  
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buffer, followed by two more stringent washes, each 
with 10 column volumes of the buffer containing  
a higher imidazole concentration (20 mmol dm–3 and  
30 mmol dm–3, respectively). N-His6-EF-Tu:GDP was 
eluted in the buffer with 200 mmol dm–3 imidazole. 
Fractions that contained N-His6-EF-Tu:GDP were pooled, 
concentrated and dialyzed against 50 mmol dm–3 Hepes-
KOH (pH = 7.5), 10 mmol dm–3 MgCl2, 50 mmol dm
–3 
KCl, glycerol (φ = 5 %), 50 μmol dm–3 GDP and  
5 mmol dm–3 β-mercaptoethanol. Glycerol was added to 
final φ = 50 % and EF-Tu:GDP was stored at –20 °C.  
Its purity was determined to be greater than 95 % by 
SDS-PAGE. 
To eliminate traces of endogenous E. coli LeuRS, 
an additional purification step by size-exclusion chro-
matography was performed using a Superdex 200 HR 
10/30 column (GE Healthcare) equilibrated in 50 mmol 
dm–3 Hepes-KOH (pH = 7.5), 10 mmol dm–3 MgCl2, 
150 mmol dm–3 NaCl, glycerol (φ = 5 %), 50 µmol dm–3 
GDP and 5 mmol dm–3 β-mercaptoethanol. Fractions 
that were enriched in EF-Tu:GDP were pooled and 
stored as previously described (see above). 
 
Overexpression and Purification of TEV Protease 
A plasmid containing the gene for His-tagged TEV 
protease was a generous gift from EMBL Protein Ex-
pression and Purification Core Facility. E. coli Rosetta 
cells transformed with the pET24-TEV plasmid were 
grown to OD600 0.6–0.8 at 37 °C. The culture was 
cooled to 15 °C before adding 0.5 mmol dm–3 IPTG, 
and the cells were allowed to grow for 15 more hours  
at 15 °C. Cell lysis was performed by sonication in 
buffer containing 50 mmol dm–3 Tris-HCl (pH = 7.5), 
300 mmol dm–3 NaCl, glycerol (φ = 10 %), 0.2 % (v / v) 
NP-40 and 10 mmol dm–3 β-mercaptoethanol. The ly-
sate was cleared by centrifugation and filtration prior to 
loading on Ni2+-NTA resin. Chromatography was per-
formed as described for EF-Tu. Fractions enriched with 
TEV protease were pooled and concentrated to 5 mg mL–1 
(precipitation was observed at higher concentrations). 
TEV protease was dialyzed against 25 mmol dm–3  
Tris-HCl (pH = 7.5), 150 mmol dm–3 NaCl, glycerol (φ 
= 10 %), and 5 mmol dm–3 β-mercaptoethanol before 
storage at –80 °C. 
 
Removal of N-terminal His-tag From N-His6-EF-Tu 
Recombinant Protein 
1 mg mL–1 N-His6-EF-Tu:GDP was incubated with 0.2 
mg mL–1 TEV protease in 50 mmol dm–3 Hepes-KOH 
(pH = 7.5), 10 mmol dm–3 MgCl2, 50 mmol dm
–3 KCl, 1 
mmol dm–3 DTT and 50 μmol dm–3 GDP overnight at 4 
°C. SDS-PAGE analysis of the reaction mixture estab-
lished that the digestion reaction reached around 90 % 
completion. His6-TEV protease, uncleaved N-His6-EF-
Tu:GDP and cleaved N-terminal His-tag were removed 
by purification on Ni2+-NTA resin. The EF-Tu:GDP 
fraction that did not bind to the resin was pooled, concen-
trated and dialyzed against storage buffer (see above). 
Glycerol was added to φ = 50 % and EF-Tu:GDP was 
stored at –20 °C. 
 
Preparation of LeuRS, tRNALeu and aa-tRNALeu 
Wild-type E. coli LeuRS and the D345A LeuRS variant 
defective in hydrolysis of aa-tRNALeu were overex-
pressed and purified by affinity chromatography on 
Ni2+-NTA resin, as described.19,27 Because LeuRS 
copurifies with leucyl-adenylate bound in the active site, 
a second purification step was performed to ensure its 
removal.19 Removal of leucyl-adenylate from the LeuRS 
active site is essential for preparative tRNALeu 
misacylation. 
The E. coli tRNALeuTAA isoacceptor was prepared 
by in vivo overexpression and purified as described.19,27 
Radiolabelling of the 3’ internucleotide linkage of tRNA 
with 32P ([32P]-tRNA) was performed by a standard 
procedure using tRNA nucleotidyl-transferase.28,29 Leu-
[32P]-tRNALeu and Nva-[32P]-tRNALeu were prepared by 
a previously published procedure.19 Briefly, approxi-
mately 0.5 µmol dm–3 [32P]-tRNALeu and 1 µmol dm–3 
D345A LeuRS were mixed in the standard LeuRS  
aminoacylation buffer. After approximately 35 min at 
37 °C, tRNALeu was recovered by phenol extraction, 
desalted on a P30-column (Micro Bio-Spin) and dia-
lyzed against 15 mmol dm–3 sodium acetate (pH = 5.0) 
prior to storage at –20 °C. The fraction of aminoacylat-
ed tRNALeu was established through P1 nuclease diges-
tion and thin-layer chromatography (TLC) analysis.19,27 
aa-tRNA was quantitated from the aa-Ap / (aa-Ap + Ap) 
ratio, where aa-Ap represents aminoacylated tRNA and 
Ap represents non-aminoacylated tRNA. 
Leu-[32P]-tRNALeu used to determine the fraction 
of active EF-Tu (see below), was prepared in a slightly 
different manner, since that assay requires use of a 
higher aa-tRNA concentration. 30 µmol dm–3 tRNALeu 
and 10 µmol dm–3 D345A LeuRS were mixed with 
roughly 200 nmol dm–3 [32P]-tRNALeu in the standard 
LeuRS aminoacylation buffer. After approximately 45 
min at 37 °C, tRNALeu was recovered by phenol extrac-
tion and ethanol precipitation. The pellet was dissolved 
in 50 mmol dm–3 sodium acetate (pH = 5.0), applied to a 
P30-column (Micro Bio-Spin) and dialyzed against 15 
mmol dm–3 sodium acetate (pH = 5.0) before storage at 
–20 °C. The final concentration of aa-tRNALeu was 
determined as described.19 
 
EF-Tu:GDP Activation 
Because EF-Tu is purified and stored as the GDP-bound 
form, it is necessary to convert the protein to the EF-
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Tu:GTP form before use. Activation of 15 µmol dm–3 
EF-Tu:GDP was performed in 70 mmol dm–3 Hepes-
KOH (pH = 7.5), 52 mmol dm–3 ammonium acetate,  
8 mmol dm–3 magnesium acetate, 30 mmol dm–3 KCl, 
0.8 mmol dm–3 DTT, 10 mmol dm–3 
phosphoenolpyruvate, 1 mmol dm–3 GTP and 0.08 U 
µL–1 pyruvate kinase at 37 °C for 2 hours. EF-Tu:GTP 
was used immediately after the activation procedure. 
 
Determination of the Fraction of Active EF-Tu:GTP 
Only a small fraction of the GTP-bound form of EF-Tu 
is able to bind aa-tRNA.30 The fraction of EF-Tu:GTP 
active in aa-tRNA binding is generally determined by an 
RNase protection assay3,4,22 that relies on the ability of 
EF-Tu:GTP to protect bound aa-tRNA from RNase 
digestion. The assay was modified in this work to allow 
TLC separation of digested and non-digested tRNAs. 
Varying amounts of EF-Tu:GTP (0–12.5 µmol dm–3, 
total protein concentration) in the activation buffer were 
mixed with saturating amounts of Leu-[32P]-tRNALeu 
(600 nmol dm–3) for 20 min at 4 °C to allow for ternary 
complex formation. 3 µL of 10 mg mL–1 RNase A were 
then added to the 30 µL reaction mixture to digest free 
(unbound) aa-tRNA. 2 µL of reaction mixture were 
taken at several time points, and were quenched in 4 µL 
of 1.5 mol dm–3 formic acid to inactivate RNase A.  
2–3 µL of this mixture were then spotted onto 
polyethyleneimine-cellulose plates (Fluka) prewashed in 
water. Separation of digested from protected aa-[32P]-
tRNA was performed by TLC in 0.1 mol dm–3 ammoni-
um acetate and acetic acid (φ = 5 %), followed by quan-
titation by phosphorimaging. The percentage of aa-
[32P]-tRNA protected from RNase A as a function of 
time was fit to a single exponential equation, and the 
fraction of aa-[32P]-tRNA initially bound to EF-Tu:GTP 
was determined from extrapolation to t = 0 (time of 
RNase A addition). The aa-tRNA fraction (bound at t = 
0) was plotted against the total EF-Tu concentration, 
and the fraction of EF-Tu:GTP molecules capable of 
binding aa-tRNA was determined from the slope of the 
linear portion of the plot.30 About 10–15 % of total 
activated EF-Tu was found to be active in aa-tRNA 
binding. Throughout this paper, concentrations of EF-
Tu:GTP refer to the concentrations of protein capable of 
aa-tRNA binding, unless otherwise stated. 
Control experiments in the absence of EF-Tu were 
performed to correct for the free aa-tRNA that was not 
digested within 15 s (first time point) after RNase A 
addition. Typically, more than 95 % of aa-tRNA was 
immediately digested and the percentage did not change 
over time. The remaining aa-tRNA background was 
subtracted from all experimental data. Control reactions 
that were performed with varying concentrations of EF-
Tu:GDP resulted in immediate digestion of more than 
95 % aa-tRNA and matched the reactions performed in 
the absence of EF-Tu. 
 
Determination of Equilibrium Dissociation Constants, 
KD at 4 °C 
Ternary complex formation was monitored by the modi-
fied RNase protection assay as described above. Briefly, 
subsaturating (1–5 nmol dm–3) amounts of aa-[32P]-
tRNA were mixed with EF-Tu:GTP and preincubated 
for 20 min at 4 °C before addition of RNase A. Concen-
trations of active EF-Tu:GTP were varied in a broad 
range (5–1400 nmol dm–3) to accurately determine KD. 
The fraction of protected aa-[32P]-tRNA was plotted 
against the concentration of active EF-Tu:GTP and the 
data were fit to the hyperbolic equation y = Y0 × [EF-
Tu:GTP] / (KD + [EF-Tu:GTP]) where Y0 is the maximal 
protected fraction and KD is the dissociation constant. 
 
Determination of Dissociation Rate Constants, koff  
at 4 °C 
The EF-Tu:GTP:aa-tRNA complex was formed by 
mixing 600 nmol dm–3 aa-[32P]-tRNA and approximate-
ly 1.5 µmol dm–3 active EF-Tu:GTP in EF-Tu activation 
buffer. The stability of the complex was monitored by 
the modified RNase protection assay. RNase A was 
added after a 20 min equilibration period at 4 °C, and 
time points were collected in a range from 0.15–15 min 
by mixing 2 µL of reaction mixture with 4 µL of  
1.5 mol dm–3 formic acid, followed by TLC analysis as 
described above. The fraction of aa-[32P]-tRNA protect-
ed from RNase A was fit to the single exponential equa-
tion y = Y0 + A × e
–koff × t where Y0 is the y intercept, A is 
the amplitude, koff is the observed dissociation rate con-
stant and t is time. 
 
Determination of Equilibrium Dissociation Constants, 
KD at 37 °C 
The assay is based on measuring the protective effect of 
a EF-Tu:GTP:aa-tRNA ternary complex on the non-
enzymatic deacylation of aa-tRNA.23,24 The reactions 
were performed by incubating EF-Tu:GTP with aa-
[32P]-tRNALeu at 37 °C in the activation buffer. aa-[32P]-
tRNALeu was present at 5–10 nmol dm–3 concentration 
and the concentration of EF-Tu:GTP was varied over a 
wide range (30–1700 nmol dm–3) to most accurately 
determine KD. Reactions were stopped at different time 
points by mixing 2 µL aliquots of reaction mixture with 
4 µL of quench solution containing 0.75 mol dm–3 sodi-
um acetate (pH = 4.5) and 1.5 g dm–3 SDS. The fraction 
of aa-tRNA in each time point was determined through 
P1 nuclease digestion and analysis on TLC plates.19 
Data were fit to the single exponential equation y = A × 
e–kobs × t where A is the amplitude, kobs is the observed 
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non-enzymatic deacylation rate constant, and t is time. 
Non-enzymatic deacylation rate constants were plotted 
against concentration of the active EF-Tu:GTP and fit to 
the equation kobs = kunprotected / (1 + [EF-Tu:GTP]/KD), 
where kunprotected is the observed constant for non-
enzymatic deacylation rate of aa-tRNA in the absence of 
EF-Tu:GTP and KD represents the dissociation constant 
of EF-Tu:GTP:aa-tRNA ternary complex.24 The speci-
ficity of the interaction was verified by control reactions 
performed with several concentrations of EF-Tu:GDP, 
where the presence of inactive EF-Tu had no protective 
effect on non-enzymatic deacylation. 
 
RESULTS 
Preparation of EF-Tu Suitable for Use in Experi-
ments With Nva-tRNALeu 
Here we study interactions of EF-Tu with Leu-tRNALeu 
and Nva-tRNALeu using modified versions of the 
ribonuclease protection and non-enzymatic hydrolysis 
protection assays.3,4,22–24 For both assays, high sensitivi-
ty to even small contamination by endogenous LeuRS 
was expected, because (i) low levels of aa-[32P]-tRNA 
were employed (because of the much higher sensitivity 
as compared with [14C]-aa-tRNA) and (ii) Nva-tRNALeu, 
an efficient (natural) substrate for hydrolytic clearance 
by LeuRS,19 was used. Further, EF-Tu:aa-tRNA interac-
tions are generally studied using high EF-Tu (total pro-
tein) concentrations, because only a small fraction of 
EF-Tu:GTP molecules are active in aa-tRNA binding.30 
This also makes analysis sensitive to contaminations in 
the protein sample. To test for the presence of endoge-
nous E. coli LeuRS, the EF-Tu:GDP was tested for Leu-
tRNALeu formation in the standard aminoacylation as-
say. Significant aminoacylation activity was observed 
with 12.5 µmol dm–3 EF-Tu:GDP (total protein concen-
tration); comparison with aminoacylation rate achieved 
by 2 nmol dm–3 LeuRS indicates a contamination level 
of approximately 0.005 % (Figure 1b).  
Next, EF-Tu:GDP was converted to EF-Tu:GTP 
and tested for interaction with Nva-tRNALeu using the 
non-enzymatic hydrolysis protection assay (see below). 
Significant hydrolysis of Nva-tRNALeu instead of pro-
tection was observed (Figure 1c), confirming that even 
low levels of copurified LeuRS preclude determination 
of EF-Tu:Nva-tRNALeu affinity. To remove these traces 
of LeuRS, EF-Tu:GDP sample was additionally purified 
by size-exclusion chromatography (see Experimental 
section). After this purification, EF-Tu:GDP showed no 
detectable leucylation activity (Figure 1b) and when 
activated to EF-Tu:GTP, it efficiently protected Nva-
tRNALeu from non-enzymatic deacylation (Figure 1c). 
This demonstrates that endogenous LeuRS was com-
pletely removed by this additional purification step.  
The Modified Ribonuclease Protection Assay 
The ribonuclease protection assay3,4,22 relies on the 
ability of EF-Tu to protect aa-tRNA from RNase A 
digestion, thus distinguishing between the bound and 
free aa-tRNA ligand. The free aa-tRNA is rapidly hy-
drolyzed by RNase A during a short incubation period, 
while the bound aa-tRNA remains protected. [14C]-amino 
acid is generally used to label the aa-tRNA, and digest-
ed and protected tRNAs are distinguished by their acid-
solubility or acid-insolubility, respectively. Thus, the 
fraction of aa-tRNA bound to EF-Tu (and thus protected 
from RNase A digestion) is commonly determined from 
the radioactivity present in the acid precipitates. Here, 
we present a modified version of this assay, where the 
different behavior of digested and protected aa-tRNAs 
in thin-layer chromatography, instead of different acid-
solubilities, are used for separation (Figure 2). The main 
advantage of this approach is that it is not complicated 
by the precipitation and filtering steps, and can be easily 
used in a high-throughput format requiring only a  
multichannel pipette and 96 well plates. We also used 
[32P]-tRNA (labeled at the terminal adenosine using 
tRNA nucleotidyl-transferase)28,29 to produce aa-[32P]-
tRNAs. Use of radiolabeled tRNA was obligatory for 
studying interactions of EF-Tu with Nva-tRNALeu be-
cause [14C]-Nva is not commercially available. 
We first incubated aa-[32P]-tRNA with RNase A, 
at the same concentrations used in the ribonuclease 
protection assay, to establish the chromatographic pat-
tern resulting from digestion (Figure 2a). tRNA used in 
all assays was aminoacylated up to 50–60 % by either 
leucine or norvaline. Incomplete aminoacylation is not 
consequential, because the presence of non-amino-
acylated tRNA does not influence EF-Tu binding affini-
ty for aa-tRNA.9 Indeed, tRNA samples with less than 
30 % of aminoacylated tRNA have previously been 
successfully used.9 tRNA is rapidly hydrolyzed within 
15 s (Figure 2a), confirming that the amount of RNase 
A is sufficient for rapid and complete digestion. We 
have also observed a substantial change in chromato-
graphic mobility that allows separate quantitation of 
digested and non-digested tRNAs. In agreement with 
previous findings,30 about 5 % of tRNA remained non-
digested or was digested in a way that does not influ-
ence its TLC mobility (Figure 2a). This value was sub-
tracted as background from all quantitated data. To 
perform reliable time-dependent measurements, very 
rapid inactivation of RNase A digestion is required 
before TLC analysis. We tested formic acid as a possi-
ble quench by preincubating aa-tRNA in 1 mol dm–3 
formic acid prior to addition of RNase A. As observed 
from Figure 2a, 98 % of tRNA was not digested within 
30 s or 30 min under these conditions. Thus, RNase A is 
rapidly inactivated in 1 mol dm–3 formic acid, making it 
a suitable quench reagent for the RNase A reaction.  
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EF-Tu:GTP Binds Nva-tRNALeu and Leu-tRNALeu 
With a Similar Affinity 
We first used the modified ribonuclease protection as-
say to test if EF-Tu discriminates between Leu-tRNALeu 
and Nva-tRNALeu. We used this assay to extract both 
equilibrium (KD) and rate (kon, koff) constants describing 
the interactions between E. coli EF-Tu and either Leu-
tRNALeu or Nva-tRNALeu, as previously described by 
Uhlenbeck and colleagues.4,5,9 
For equilibrium measurements, various concen-
trations of EF-Tu:GTP (EF-Tu:GDP was converted to 
EF-Tu:GTP immediately prior to use) were incubated 
for 25 min at 4 °C with either Leu-[32P]-tRNALeu or 
Nva-[32P]-tRNALeu. Bound and unbound aa-[32P]-
tRNA were distinguished by short incubation with 
RNase A, where only unbound aa-tRNA has been 
digested, followed by quenching in formic acid (to 
inactivate RNase) and separation from the bound aa-
tRNA by TLC (for details see Experimental). Digested 
and protected tRNAs (representing unbound and bound 
tRNAs, respectively) were independently quantitated 
(Figure 2b), and the fraction of bound aa-tRNA was 
calculated and plotted against the concentration of 
active EF-Tu:GTP (for determination of the fraction of 
active EF-Tu:GTP see Experimental section) (Figure 
3a). Our data show that EF-Tu:GTP binds Leu-
tRNALeu and Nva-tRNALeu with similar affinity (70 
nmol dm–3 and 24 nmol dm–3, respectively, Figure 3a 
and Table 1). To the best of our knowledge, these are 
the first data showing interaction of EF-Tu with 
norvalylated tRNA. The similar affinities measured for 
Leu-tRNALeu and Nva-tRNALeu are consistent with the 
data showing incorporation of norvaline in cellular 
proteins under some conditions.14,15 
Next, we determined the dissociation rate con-
stants of Leu-tRNALeu and Nva-tRNALeu (koff) from their 
corresponding EF-Tu:GTP:aa-tRNA ternary complexes 
using the modified version of ribonuclease protection 
assay. The rationale was to examine if kinetics of asso-
ciation (kon and koff) significantly differs for these two 
aa-tRNAs, in spite of the similar overall KD. EF-
Tu:GTP and aa-tRNA were incubated for 25 min at 4 °C 
followed by RNase A addition. Time points were taken 
at regular intervals, and the reaction was quenched in 1 
mol dm–3 formic acid. Digested and protected tRNAs 
were separated as described for the equilibrium meas-
urements (Figure 2). The fraction of remaining bound 
aa-tRNA was plotted vs. time, and first order rate con-
stant representing koff was extracted (Figure 3b). Similar 
to our findings with respect to equilibrium constants, the 
dissociation rate constants (koff) for Leu-tRNA
Leu and 
Nva-tRNALeu are also highly similar (Figure 3a and 
Table 1). Taken together, our data clearly show that 
neither equilibrium binding nor association kinetics 
differ significantly between EF-Tu:GTP:Leu-tRNALeu 
and EF-Tu:GTP:Nva-tRNALeu ternary complexes. Thus, 
E. coli EF-Tu does not distinguish between Leu-
tRNALeu and Nva-tRNALeu. 
Figure 2. Characteristic RNase digestion pattern obtained by thin-layer chromatography. The thin-layer chromatogram represents
a time course obtained by incubating Leu-[32P]-tRNALeu with RNase A in the absence of EF-Tu:GTP (left side of the panel, -EF-
Tu:GTP) and a quench control performed by adding RNase A to Leu-[32P]-tRNALeu mixed with 1 mol dm–3 formic acid (right side
of the panel, quench control). Digested and non-digested tRNAs were separately quantitated with ImageQuant software and the
fraction of non-digested tRNA was calculated by dividing the intensity of non-digested tRNA with the total intensity. To calculate
the fraction of non-digested aa-tRNA, the fraction of non-digested tRNA was divided by the fraction of aa-tRNA initially present
in the sample (a). Representative thin-layer chromatogram of a time course obtained in the modified RNase protection assay
where RNase A was added to a mixture of Leu-[32P]-tRNALeu and EF-Tu:GTP preincubated at 4 °C (b).  
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Discrimination of Norvaline by EF-Tu:GTP is not 
Enhanced at the Physiologically Relevant Temperature 
The data so far presented describes the EF-Tu:GTP:aa-
tRNA interactions at 4 °C, a temperature that is not 
physiologically highly relevant, but is commonly used 
in EF-Tu binding studies. Two main advantages of 
working at lower temperatures are (i) higher affinity of 
EF-Tu:GTP for aa-tRNA and (ii) significantly slower 
aa-tRNA dissociation rate allowing manual sampling of 
time points.4,31 However, there is a possibility that EF-
Tu:GTP discriminates better against Nva-tRNALeu at the 
physiologically more relevant temperature. To experi-
mentally address this issue, we used a different as-
say,23,24 better suited for the work at higher tempera-
tures. This assay is based on protection of aa-tRNA 
from non-enzymatic hydrolysis in solution, when it is 
bound  to  EF-Tu:GTP. The GDP-bound  form of EF-Tu 
was firstly converted to the GTP-bound form prior to 
mixing with aa-[32P]-tRNA at 37 °C. At certain time 
points, reaction aliquots were quenched, tRNA was 
degraded using P1 nuclease, and products were ana-
lyzed by TLC as described.19,27 Representative time 
courses obtained at different concentrations of active 
EF-Tu:GTP are shown in Figure 4a. As expected, at 
higher concentrations of EF-Tu:GTP, the pre-equi-
librium is shifted toward preferential binding of aa-
tRNA, thus decreasing the rate of non-enzymatic hy-
drolysis (i.e. better protection is observed). As a control, 
the same experiment was performed with EF-Tu:GDP 
(Figure 4b). No protection of Leu-tRNALeu was ob-
served, confirming the specificity of interactions meas-
ured in Figure 4a. The dependence of kobs vs. concentra-
tion of the active EF-Tu:GTP yields KD (Figure 4c and 
Table 1). Interestingly, a similar level of discrimination 
is observed at 37 °C and 4 °C, which further demon-
Figure 4. Interaction of E. coli EF-Tu:GTP with Leu- or Nva-[32P]-tRNALeu at 37 °C. Representative Leu-[32P]-tRNALeu non-
enzymatic deacylation time courses in the presence of 0 (●), 28 (○), 70 (), 140 (), 280 (), 420 (), 700 () and 1120 ()
nmol dm–3 active EF-Tu:GTP (a). Control non-enzymatic Leu-[32P]-tRNALeu deacylation time courses in the presence of 0 (●), 1
(○), 5 () and 10 () µmol dm–3 EF-Tu:GDP (total protein concentration) (b). Equilibrium binding curves showing affinity of
E.coli EF-Tu:GTP for Leu-tRNALeu (●) or Nva-tRNALeu (○) (c). 
Figure 3. Interaction of E. coli EF-Tu:GTP with Leu- or Nva-[32P]-tRNALeu at 4 °C. Equilibrium binding curves showing affinity
of E. coli EF-Tu:GTP for Leu-tRNALeu (●) or Nva-tRNALeu (○) (a). Time courses depicting Leu-tRNALeu (●) or Nva-tRNALeu (○)
dissociation from aa-tRNALeu:EF-Tu:GTP ternary complex. The control experiment was performed with EF-Tu:GDP () (b). 
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strates that Nva-tRNALeu and Leu-tRNALeu are equally 




Quality control of protein translation is manifested at 
several steps: formation of aa-tRNAs by aaRSs, EF-
Tu:GTP dependent delivery of aa-tRNAs to the ribo-
some, and the subsequent mRNA decoding, where the 
anticodon of aa-tRNA is matched with the cognate co-
don to ensure incorporation of the esterified amino acid 
at the appropriate position in the growing polypeptide 
chain. Each of these steps possesses an inherent error 
frequency and mechanism to maintain error rates within 
the level tolerable in protein synthesis (10–3–10–4).16 
Prompted by the findings that the non-proteinogenic 
amino acid norvaline partially evades translational 
proofreading mechanisms, and is thus incorporated into 
proteins in place of leucine under some conditions in 
vivo,14,15 we have recently analyzed in detail the capaci-
ty of E. coli LeuRS to discriminate against formation of 
Nva-tRNALeu.19 In agreement with previous findings,18 
norvaline was indeed determined to be a reasonably 
good substrate for the LeuRS synthetic reactions. How-
ever, accumulation of Nva-tRNALeu was not observed 
due to its rapid hydrolysis (the single turnover rate con-
stant is 300 s–1) within the LeuRS CP1 editing site.19 
Here, we further explore the capacity of Nva-tRNALeu to 
bind EF-Tu:GTP. The rationale was to determine 
whether any Nva-tRNALeu that evades LeuRS hydrolytic 
editing may participate efficiently in the subsequent step 
in translation.  
First, we tested equilibrium binding of Nva-tRNALeu 
and Leu-tRNALeu to EF-Tu:GTP at 4 °C using a modi-
fied version of the commonly used ribonuclease protec-
tion assay to extract KD values. Previous work has 
shown that all elongator aa-tRNAs bind E. coli EF-
Tu:GTP similarly, with only a 12-fold range in the KD 
values.3 Thus, the 3-fold difference in KD values for 
Nva-tRNALeu and Leu-tRNALeu (Table 1) strongly sug-
gests that Nva-tRNALeu is indistinguishable from Leu-
tRNALeu and other elongator cognate aa-tRNAs regard-
ing its interaction with EF-Tu. Moreover, the observed 
KD values are very similar to the previously determined 
KD for E. coli Phe-tRNA
Phe under comparable ionic 
strength conditions.32 Analysis of association kinetics 
revealed the same pattern. koff for Nva-tRNA
Leu and 
Leu-tRNALeu differs by less than 2-fold (Table 1) and 
the values are highly similar to the previously deter-
mined koff for Phe-tRNA
Phe.31,32 In general, EF-Tu KD 
values are less accurate than koff values because of the 
error-prone determination of the active EF-Tu:GTP 
fraction, which is a prerequisite for KD extraction (Fig-
ure 3). Because kon was shown to be constant for differ-
ent aa-tRNAs,32 KD is often calculated from the kon val-
ue32 (1.1 × 105 mol–1 dm3 s–1) and the experimentally 
determined koff.
5,12,30 Here, we calculated kon from the 
experimentally measured KD and koff values for both 
Leu-tRNALeu and Nva-tRNALeu. The values obtained 
(Table 1) are very similar to each other and to the previ-
ously determined kon value. This provides considerable 
confidence in the reported thermodynamic and kinetic 
parameters and strongly supports the conclusion that 
Nva-tRNALeu is not discriminated in translation at the 
level of EF-Tu:GTP binding.  
Additional proof was obtained from the analysis of EF-
Tu:GTP interactions with both Nva-tRNALeu and Leu-
tRNALeu at the physiologically more relevant tempera-
ture of 37 °C. Here we used an assay that relies on pro-
tection of aa-tRNA from solution-based non-enzymatic 
hydrolysis when bound to EF-Tu:GTP.23,24 Again, the 
extracted KD values for Nva-tRNA
Leu and Leu-tRNALeu 
(Table 1) were highly similar, demonstrating that dis-
crimination against norvaline is independent of tempera-
ture. We also show that aa-tRNA binds EF-Tu:GTP 
weaker at higher temperatures, consistent with previ- 
ous observations.4,31 The absence or presence of the  
N-terminal His6-tag on EF-Tu did not influence its in-
teractions with aa-tRNAs (Table 1).  
According to the thermodynamic compensation model,4 
the contributions of the esterified amino acid and the 
tRNA body are independent of one another, but com-
pensate such that all cognate aa-tRNA pairs have similar 
binding affinities. Because fine tuning of binding affini-
ties by the compensation mechanism is disturbed in 
misacylated tRNAs, these species bind EF-Tu:GTP over 
a broad range of affinities, varying from 60-fold weaker 
Table 1. Thermodynamic and kinetic parameters describing EF-Tu:GTP:aa-tRNA interactions. The values represent the best fit 
value ± s.e.m. of three independent experiments. 
aa-tRNALeu KD (4 °C) /  
nmol dm–3 
koff (4 °C) / 
min–1
kon (4 °C) calculated
(a) /  
mol–1 dm3 min–1
KD (37 °C) / 
nmol dm–3
Leu-tRNALeu 70 ± 9    0.67 ± 0.05(b)              9.5 × 106        (18 ± 2) × 10(c) 
Nva-tRNALeu 24 ± 4     0.36 ± 0.05              15 × 106      (13 ± 1) × 10 
(a) kon = koff / KD 
(b) 1.3 ± 0.2 min–1 determined with N-His6-EF-Tu:GTP
 
(c) (19 ± 2) × 10 nmol dm–3 determined with N-His6-EF-Tu:GTP 
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to 120-fold tighter as compared with cognate aa-tRNA 
pairs.5 This apparently depresses utilization of at least 
some misacylated tRNAs in translation, and thus EF-Tu 
may act as a checkpoint for translational fidelity.10–12 
Structural33,34 and thermodynamic analyses5 revealed 
that amino acids bind in the same pocket on the surface 
of EF-Tu, but establish slightly different contacts that 
result in different binding affinities. Lack of discrimina-
tion against Nva-tRNALeu suggests that both norvaline 
and leucine establish interactions with EF-Tu:GTP that 
are thermodynamically comparable. Inspection of 
Thermus thermophilus EF-Tu interactions with specifi-
cally designed misacylated tRNAs revealed that valine 
binds approximately 2-fold weaker than the slightly 
bigger isoleucine.5 Comparison of the measured koff 
values (Table 1) revealed that norvaline, although 
smaller, binds EF-Tu approximately 1.5-fold tighter 
than leucine. Thus, it is likely that norvaline compen-
sates for the lack of the methyl group binding energy by 
establishing better interactions of its unbranched side 
chain within the EF-Tu binding pocket.  
Our extensive kinetic analysis demonstrated that wild-
type LeuRS very efficiently clears Nva-tRNALeu in 
vitro.19 However, anything that disturbs the kinetic 
partitioning of Nva-tRNALeu between post-transfer 
editing hydrolysis and dissociation (either via com-
promising hydrolytic activity or stimulating dissocia-
tion) may result in accumulation of Nva-tRNALeu. It is 
not yet understood what factors may influence kinetic 
partitioning of Nva-tRNALeu in vivo. However, what 
we clearly established here is that after Nva-tRNALeu is 
released from LeuRS, it binds EF-Tu as efficiently as 
Leu-tRNALeu or any other elongator aa-tRNA. This 
explains the occurrence of norvaline incorporation in 
place of leucine in vivo, under conditions where its 
accumulation allows efficient activation by LeuRS.14,15 
Taken together, these findings strongly suggest that 
hydrolytic editing by LeuRS serves as the main quality 
control checkpoint against incorporation of norvaline 
into cellular proteins. Indeed, when LeuRS hydrolytic 
editing was compromised, a significant substitution of 
leucine by norvaline was observed in a reporter protein 
in vivo.18 Similarly, mistranslation of phenylalanine 
codons by tyrosine parallels the utilization of an edit-
ing-deficient phenylalanyl-tRNA synthetase (PheRS) 
in poly(U)-directed polyTyr/polyPhe synthesis assay. 
In this case it was shown that mistranslation occurs in 
part from the inability of E. coli EF-Tu to discriminate 
between Phe-tRNAPhe and Tyr-tRNAPhe.31 One may 
argue that because of efficient editing by aaRSs, such 
as PheRS35,36 and LeuRS,19,37,38 EF-Tu was not subject 
to evolutionary pressure to develop stringent discrimi-
nation against Tyr-tRNAPhe and Nva-tRNALeu. Thus, 
EF-Tu may have preferentially evolved towards effi-
cient elimination of commonly occurring mischarged 
intermediates such as Glu-tRNAGln and Asp-
tRNAAsn.4,9–11,24 The failure of EF-Tu to discriminate 
among some aminoacyl-tRNA substrates places the 
main burden of translational fidelity on the corre-
sponding aaRSs. It appears that the interplay between 
attainable accuracies in cognate aa-tRNA formation 
and EF-Tu recognition may have driven evolution, at 
least in the case of LeuRS, towards acquisition of the 
highly efficient hydrolytic site that prevents accumula-
tion of Nva-tRNALeu for mistranslation. 
Abbreviations. aaRS, aminoacyl-tRNA synthetase; aa-tRNA, 
aminoacyl-tRNA; CP1, connective peptide 1; EF-Tu, elonga-
tion factor Tu; LeuRS, leucyl-tRNA synthetase; Nva, 
norvaline; PheRS, phenylalanyl-tRNA synthetase; RNase, 
ribonuclease; TEV, tobacco etch virus; TLC, thin-layer 
chromatography; WT, wild-type. 
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